About us

SANEMUS AG focuses on investing in company and asset shares in the German healthcare market and offers strategic, financial and merger&acquisition advisory in this context. It was founded in 2006 by experienced healthcare professionals in Munich. The investment focus is exclusively put on the Life Science sector with its submarkets pharmaceutical industry, biotechnology, medical technology, diagnostics and E-health.

Our Mission

We assist to develop commercially attractive companies from promising Start-Ups from the Life Science sector due to the complementary strategic and financial advisory services offered.

We provide strategic input to substantially increase the value of Life Science companies by sophisticated lifecycle und portfolio management as well as strategic partnering.

We advise investors in Life Science investments – either in single investment projects or in Venture Capital or Private Equity Funds – to achieve an individually optimal value increase of their investments.

Current news

40 years of German biotechnology – a look back and ahead

In his latest article on transkript.de, Dr. Michael H. Thiel takes an exciting look back at the development of German biotechnology – and at the same time offers an optimistic outlook for the coming years. From the first start-ups in the…

More than 100 times the sensitivity: SANEMUS supports disruptive LFA technology

SANEMUS is pleased to support a promising start-up in its search for investors. The start-up is developing a groundbreaking platform technology that serves as a high-precision signal amplifier. The goal is to increase the sensitivity of lateral…

Ophthalmology project update

The ophthalmology project we are supporting is developing positively. The market entry strategy for Europe is currently being developed. If you are interested in the project or an investment, please contact us.

Gait analysis system for fast and targeted medication adjustment for Parkinson’s patients

The SANEMUS AG team is supporting a German e-health startup in its search for capital. The startup is developing an innovative gait analysis system for fast and targeted medication adjustment for Parkinson's patients that is reimbursed by health…
Partners